2026-11-19 18:21 UTC
DANGMUAAI & Developer Tools, Decoded
BackIndustry

Anthropic Opens at $111.50 in the Most Valuable IPO Ever

Anthropic opened at $111.50, 33% above its $83 IPO price, raising over $81 billion. The numbers, the safety pitch, and who actually controls the company.

DangMua EditorialNov 19, 20265 min read
Anthropic Opens at $111.50 in the Most Valuable IPO Ever

Anthropic opened on the Nasdaq at $111.50 on November 19, a 33% premium over its $83 IPO price — the most valuable IPO on record. The offering raised more than $81 billion, handing a company built on slowing AI down the balance sheet to speed it up.

What the numbers say

TechCrunch reports that the $83 IPO price was already above the company's own projected range of $70 to $78 per share. At the opening price, the publication puts Anthropic's market cap "over $2 trillion, making it more valuable than Meta, Tesla, or Walmart," with only five companies ahead of it: Apple, Amazon, Alphabet, Nvidia, and Microsoft. The Verge reports the stock trades under the ticker ANT, and values the company at around $1.5 trillion at the $83 pricing — the gap between the two figures is the opening-day pop, not a disagreement about the arithmetic.

The cash position is the number that matters for everything Anthropic does next. TechCrunch reports the IPO proceeds, combined with existing fundraising and new private offerings timed to the debut, will leave the company with an expected $220 billion in cash reserves. One analyst told the publication that "Anthropic's going to have more cash on hand than any company has ever had."

The S-1 filing is less flattering in isolation. The Verge reports Anthropic recorded an $80.7 billion net loss in the first half of this year, noting that most of it comes from an accounting charge that does not reflect the underlying business, alongside $16.3 billion in revenue. Those two figures belong together; quoted apart, either one misleads.

The safety pitch, delivered at the opening bell

Dario Amodei used the Nasdaq podium to restate the company's founding position rather than its growth story. "To state it unequivocally, we will pace the training and deployment of AI systems, taking as long as is necessary to have confidence that they are safe and will remain under human control," Amodei said, according to Reuters as reported by The Verge. "We will not bend to either business nor political pressure."

In remarks reported by TechCrunch, he tied the financing directly to that commitment: "Today puts the company in a stronger financial position, and in doing so, only strengthens our resolve to do the right thing. If we can show it's possible to make the right choices on safety and still build an incredibly successful company, others in our industry will be inspired to do the same. We call this a race to the top."

The risk disclosures are unusual

Public filings are written to limit liability, which makes Anthropic's language worth reading closely. The Verge reports the S-1 lists possible "catastrophic" risks tied to its own models, including "self-preserving behaviors" like resisting attempts to shut them down. The filing also warns shareholders that the company's models "may behave in unintended, misaligned, or autonomous ways" that can harm Anthropic itself.

For a prospective investor, those are disclosures about the product, not about market conditions. Few S-1s describe the core asset as a potential source of catastrophic risk.

Who actually controls the company

The governance structure is the part that separates this listing from a conventional tech IPO. The Verge reports Anthropic is registered as a Public Benefit Corporation, meaning the board carries a responsibility to balance its mission against shareholder wealth maximization. Its Long-Term Benefit Trust, introduced in 2023, and its founders hold controlling voting rights — so, as the publication puts it, they would "never be able to be voted out by shareholders even as a public company." A special class of stock, Class T, gives the trust's small group of trustees authority to select and remove part of the board.

The checks are narrower than the structure suggests. The Verge reports the trust technically chooses four members of a seven-person board, but one of those four effectively needs founder approval, "leaving the trust short of straightforward majority control." Removing or nominating a director also requires 30 days' notice to a three-member nominating and governance committee chaired by co-founder Daniela Amodei.

Analysis: a structure that insulates leadership from shareholder pressure to chase profit is the same structure that insulates it from shareholder pressure of any kind. Investors buying ANT are buying exposure to decisions they cannot vote on.

The internal view is not unanimous

The Verge quotes one former employee who left ahead of the IPO saying he and others had increasingly felt the current pace of AI development is "untenable under normal market structures," pointing to mismatched incentives in an industry with little to no oversight. That is one unnamed former employee characterizing internal sentiment, not a measured figure — but it is the clearest public signal of the tension the listing creates.

The same publication frames the debut as beating SpaceX for the most valuable IPO of all time, having raised $81.3 billion, and as setting a precedent for the AI lab listings expected to follow.

What to watch next

  • Whether the opening-day premium holds once the first lockup and post-IPO disclosure cycle arrives — the opening price, not the IPO price, is what produced the $2 trillion headline.
  • How the $220 billion cash position is deployed against compute commitments, and whether the pacing language survives contact with that spending.
  • Whether the Long-Term Benefit Trust ever exercises its board powers in a way shareholders can observe.
  • Which lab lists next, and whether it copies the Public Benefit Corporation structure or drops it.

The listing resolves Anthropic's funding question and sharpens its governance one. The company now has more capital than any lab has ever held to pursue a strategy whose central promise is restraint.

More from DangMua